# Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

> **NCT00696345** · — · COMPLETED · sponsor: **Epigenomics, Inc** · enrollment: 700 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00696345
- **Lead sponsor:** Epigenomics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-10
- **Final completion:** 2007-02
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696345, "Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00696345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*